373 related articles for article (PubMed ID: 32951278)
1. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma.
Zhao Y; Xue C; Xie Z; Ouyang X; Li L
Cell Prolif; 2020 Oct; 53(10):e12908. PubMed ID: 32951278
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
3. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit.
Chen Z; Ma Y; Guo Z; Song D; Chen Z; Sun M
Ann Hepatol; 2022; 27(2):100669. PubMed ID: 35045360
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific protease 1 inhibition sensitizes hepatocellular carcinoma cells to doxorubicin by ubiquitinated proliferating cell nuclear antigen-mediated attenuation of stemness.
Lu Z; Zhang Z; Yang M; Xiao M
Anticancer Drugs; 2022 Aug; 33(7):622-631. PubMed ID: 35324534
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
7. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells.
Liao Y; Shao Z; Liu Y; Xia X; Deng Y; Yu C; Sun W; Kong W; He X; Liu F; Guo Z; Chen G; Tang D; Gan H; Liu J; Huang H
J Exp Clin Cancer Res; 2021 Jun; 40(1):201. PubMed ID: 34154657
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met.
Chen JJ; Sun X; Mao QQ; Jiang XY; Zhao XG; Xu WJ; Zhong L
Kaohsiung J Med Sci; 2020 Mar; 36(3):196-205. PubMed ID: 31749294
[TBL] [Abstract][Full Text] [Related]
10. USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis.
Liu D; Li Q; Zang Y; Li X; Li Z; Zhang P; Feng C; Yang P; Cui J; Sun Y; Wei T; Su P; Zhao X; Yang H; Ding Y
Cell Death Dis; 2023 Apr; 14(4):264. PubMed ID: 37041150
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells.
Kuang X; Xiong J; Lu T; Wang W; Zhang Z; Wang J
Int J Med Sci; 2021; 18(1):245-255. PubMed ID: 33390793
[TBL] [Abstract][Full Text] [Related]
12. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
13. USP1 (ubiquitin specific peptidase 1) targets ULK1 and regulates its cellular compartmentalization and autophagy.
Raimondi M; Cesselli D; Di Loreto C; La Marra F; Schneider C; Demarchi F
Autophagy; 2019 Apr; 15(4):613-630. PubMed ID: 30335599
[TBL] [Abstract][Full Text] [Related]
14. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma.
Cai X; Deng J; Zhou J; Cai H; Chen Z
BMC Gastroenterol; 2021 Oct; 21(1):377. PubMed ID: 34649520
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling.
Li S; Gu H; Huang Y; Peng Q; Zhou R; Yi P; Chen R; Huang Z; Hu X; Huang Y; Tang D
Cell Cycle; 2018; 17(19-20):2349-2359. PubMed ID: 30265210
[TBL] [Abstract][Full Text] [Related]
17. Identification and analysis of C17orf53 as a prognostic signature for hepatocellular carcinoma.
Zhao Y; Zhang L; Hu Q; Zhu D; Xie Z
Comput Biol Med; 2023 Jan; 152():106348. PubMed ID: 36470143
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
[TBL] [Abstract][Full Text] [Related]
19. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
[TBL] [Abstract][Full Text] [Related]
20. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
